WEBINAR ON-DEMAND

Generating Real-World Evidence for Alzheimer’s Disease Research: How Your Patients and Care Partners Can Enroll in TB-REAL US

Early-stage detection of mild cognitive impairment, dementia and Alzheimer’s Disease remains a critical challenge. And when timely intervention can improve outcomes, it’s more important than ever to participate in research opportunities to help understand the patient journey.

Watch our on-demand virtual event, hosted by Premier, where experts will discuss:

• Patient and care partner enrollment process in Eli Lilly and Company’s “Long-Term Real-World Comparative Effectiveness of Donanemab Plus Usual Care Versus Usual Care Alone in US Patients with Early Symptomatic Alzheimer’s Disease (TRAILBLAZER-REAL US)” study, and how your health system can participate as a study site
  
• Measuring care partner stress
  
• Using clinical decision support (CDS) alerts to identify eligible patients
  
• Qualitative insights shared by dementia and Alzheimer’s Disease experts on the importance of real-world data collection to better understand the journey of early-stage Alzheimer’s Disease patients and associated care partner stress
  
• The future of dementia care

SPEAKERS:

Brent P. Forester MD, Msc.
Chief and Chairman, Department of Psychiatry, Tufts Medical Center
Co-Physician Executive, Neuroscience and Behavioral Health Service Line, Tufts Medicine

Valeria C. Baldivieso, MD
Memory Care Medical Director
AdventHealth Medical Group Memory Care | Central Florida Division

CONTACT INFORMATION